{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:31Z","timestamp":1790763031343,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41440-022-01018-8","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T06:05:41Z","timestamp":1663221941000},"page":"1823-1831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trends in antihypertensive prescription for pregnant women with hypertension and their peripartum outcomes before and after label and guideline revisions in Japan"],"prefix":"10.1038","volume":"45","author":[{"given":"Reina","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Shigemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"1018_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/bcp.13469","volume":"84","author":"T Goedecke","year":"2018","unstructured":"Goedecke T, Morales DR, Pacurariu A, Kurz X. Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations: Methods for measuring impact of medicines regulatory interventions. Br J Clin Pharmacol. 2018;84:419\u201333.","journal-title":"Br J Clin Pharmacol"},{"key":"1018_CR2","doi-asserted-by":"publisher","first-page":"e99021","DOI":"10.1371\/journal.pone.0099021","volume":"9","author":"S Nakaoka","year":"2014","unstructured":"Nakaoka S, Ishizaki T, Urushihara H, Satoh T, Ikeda S, Yamamoto M, et al. Prescribing pattern of anti-parkinson drugs in Japan: a trend analysis from 2005 to 2010. PLoS ONE. 2014;9:e99021.","journal-title":"PLoS ONE"},{"key":"1018_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1248\/bpb.b17-00266","volume":"40","author":"M Takeyama","year":"2017","unstructured":"Takeyama M, Sai K, Imatoh T, Segawa K, Hirasawa N, Saito Y. Influence of Japanese regulatory action on denosumab-related hypocalcemia using Japanese adverse drug event report database. Biol Pharm Bull. 2017;40:1447\u201353.","journal-title":"Biol Pharm Bull"},{"key":"1018_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/11588230-000000000-00000","volume":"34","author":"N Ooba","year":"2011","unstructured":"Ooba N, Yamaguchi T, Kubota K. The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008. Drug Saf. 2011;34:329\u201339.","journal-title":"Drug Saf"},{"key":"1018_CR5","doi-asserted-by":"publisher","first-page":"e026076","DOI":"10.1136\/bmjopen-2018-026076","volume":"9","author":"F Drogou","year":"2019","unstructured":"Drogou F, Netboute A, Giai J, Dode X, Darmon D, Kassai B, et al. Off-label drug prescriptions in French general practice: a cross-sectional study. BMJ Open. 2019;9:e026076.","journal-title":"BMJ Open"},{"key":"1018_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1211\/ijpp.18.04.0007","volume":"18","author":"C Herring","year":"2010","unstructured":"Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women\u2019s Hospital. Int J Pharm Pract. 2010;18:226\u20139.","journal-title":"Int J Pharm Pract"},{"key":"1018_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5649\/jjphcs.35.267","volume":"35","author":"N Kohyama","year":"2009","unstructured":"Kohyama N, Morizane T, Inoue N, Hada N, Murashima A, Nakamoto O, et al. Survey of physicians, obstetricians and gynecologists regarding prescription of calcium blockers during pregnancy. Iryo Yakugaku Jpn J Pharm Health Care Sci. 2009;35:267\u201380.","journal-title":"Iryo Yakugaku Jpn J Pharm Health Care Sci"},{"key":"1018_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/j.1447-0756.2011.01653.x","volume":"37","author":"H Minakami","year":"2011","unstructured":"Minakami H, Hiramatsu Y, Koresawa M, Fujii T, Hamada H, Iitsuka Y, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition: Guidelines for obstetrical practice. J Obstet Gynaecol Res. 2011;37:1174\u201397.","journal-title":"J Obstet Gynaecol Res"},{"key":"1018_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/jog.12419","volume":"40","author":"H Minakami","year":"2014","unstructured":"Minakami H, Maeda T, Fujii T, Hamada H, Iitsuka Y, Itakura A, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition: 2014 Guidelines for obstetrical practice. J Obstet Gynaecol Res. 2014;40:1469\u201399.","journal-title":"J Obstet Gynaecol Res"},{"key":"1018_CR10","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/pds.4654","volume":"27","author":"T Ishikawa","year":"2018","unstructured":"Ishikawa T, Obara T, Nishigori H, Miyakoda K, Ishikuro M, Metoki H, et al. Antihypertensives prescribed for pregnant women in Japan: prevalence and timing determined from a database of health insurance claims. Pharmacoepidemiol Drug Saf. 2018;27:1325\u201334.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1018_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2188\/jea.JE20090066","volume":"20","author":"S Kimura","year":"2010","unstructured":"Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20:413\u20139.","journal-title":"J Epidemiol"},{"key":"1018_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ijgo.13477","volume":"153","author":"D Shigemi","year":"2021","unstructured":"Shigemi D, Hashimoto Y, Michihata N, Yasunaga H. Effect of Japanese herbal Kampo medicines on live birth rate in women with recurrent pregnancy loss. Int J Gynecol Obstet. 2021;153:489\u201395.","journal-title":"Int J Gynecol Obstet"},{"key":"1018_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ijgo.12781","volume":"145","author":"N Michihata","year":"2019","unstructured":"Michihata N, Shigemi D, Sasabuchi Y, Matsui H, Jo T, Yasunaga H. Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum. Int J Gynecol Obstet. 2019;145:182\u20136.","journal-title":"Int J Gynecol Obstet"},{"key":"1018_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2020.07.011","volume":"220","author":"Y Hashimoto","year":"2020","unstructured":"Hashimoto Y, Michihata N, Yamana H, Shigemi D, Morita K, Matsui H, et al. Ophthalmic corticosteroids in pregnant women with allergic conjunctivitis and adverse neonatal outcomes: propensity score analyses. Am J Ophthalmol. 2020;220:91\u2013101.","journal-title":"Am J Ophthalmol"},{"key":"1018_CR15","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/CIRCULATIONAHA.120.052624","volume":"143","author":"H Kaneko","year":"2021","unstructured":"Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, et al. Association of Blood Pressure Classification Using the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation. Circulation. 2021;143:2244\u201353.","journal-title":"Circulation"},{"key":"1018_CR16","doi-asserted-by":"publisher","first-page":"e022479","DOI":"10.1161\/JAHA.121.022479","volume":"10","author":"H Kaneko","year":"2021","unstructured":"Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, et al. Untreated hypertension and subsequent incidence of colorectal cancer: analysis of a nationwide epidemiological database. J Am Heart Assoc. 2021;10:e022479.","journal-title":"J Am Heart Assoc"},{"key":"1018_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinepi.2018.03.004","volume":"99","author":"K Hara","year":"2018","unstructured":"Hara K, Tomio J, Svensson T, Ohkuma R, Svensson AK, Yamazaki T. Association measures of claims-based algorithms for common chronic conditions were assessed using regularly collected data in Japan. J Clin Epidemiol. 2018;99:84\u201395.","journal-title":"J Clin Epidemiol"},{"key":"1018_CR18","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.3390\/ijerph19084864","volume":"19","author":"K Tajima","year":"2022","unstructured":"Tajima K, Ishikawa T, Matsuzaki F, Noda A, Morishita K, Inoue R, et al. Validity of administrative data for identifying birth-related outcomes with the end date of pregnancy in a Japanese University Hospital. Int J Environ Res Public Health. 2022;19:4864.","journal-title":"Int J Environ Res Public Health"},{"key":"1018_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41371-020-0312-x","volume":"35","author":"X Li","year":"2021","unstructured":"Li X, Zhang W, Lin J, Liu H, Yang Z, Teng Y, et al. Hypertensive disorders of pregnancy and risks of adverse pregnancy outcomes: a retrospective cohort study of 2368 patients. J Hum Hypertens. 2021;35:65\u201373.","journal-title":"J Hum Hypertens"},{"key":"1018_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.preghy.2021.07.244","volume":"25","author":"A Ueda","year":"2021","unstructured":"Ueda A, Chigusa Y, Mogami H, Nakita B, Ohtera S, Kato G, et al. Maternal near-miss attributable to haemorrhagic stroke in patients with hypertensive disorders of pregnancy in Japan: a national cohort study. Pregnancy Hypertens. 2021;25:240\u20133.","journal-title":"Pregnancy Hypertens"},{"key":"1018_CR21","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/ijerph18073342","volume":"18","author":"K Poudel","year":"2021","unstructured":"Poudel K, Kobayashi S, Miyashita C, Ikeda-Araki A, Tamura N, Ait Bamai Y, et al. Hypertensive disorders during pregnancy (HDP), maternal characteristics, and birth outcomes among Japanese women: a Hokkaido study. Int J Environ Res Public Health. 2021;18:3342.","journal-title":"Int J Environ Res Public Health"},{"key":"1018_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.preghy.2020.09.008","volume":"22","author":"Y Noh","year":"2020","unstructured":"Noh Y, Choe SA, Shin JY. A cohort study of antihypertensive use during pregnancy in South Korea, 2013\u20132017. Pregnancy Hypertens. 2020;22:167\u201374.","journal-title":"Pregnancy Hypertens"},{"key":"1018_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.preghy.2011.01.001","volume":"1","author":"V Duhalde","year":"2011","unstructured":"Duhalde V, Delarue C, Lacroix I, Suarez C, Bourrel R, Montastruc JL, et al. Antihypertensive drug prescription pattern before and during pregnancy in France. Pregnancy Hypertens. 2011;1:185\u20139.","journal-title":"Pregnancy Hypertens"},{"key":"1018_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","volume":"327","author":"LA Magee","year":"2003","unstructured":"Magee LA. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327:955\u201360.","journal-title":"BMJ"},{"key":"1018_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajog.2020.03.016","volume":"223","author":"I Bellos","year":"2020","unstructured":"Bellos I, Pergialiotis V, Papapanagiotou A, Loutradis D, Daskalakis G. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. Am J Obstet Gynecol. 2020;223:525\u201337.","journal-title":"Am J Obstet Gynecol"},{"key":"1018_CR26","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1681\/ASN.2014050459","volume":"26","author":"GB Piccoli","year":"2015","unstructured":"Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N, et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol. 2015;26:2011\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"1018_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41440-022-00853-z","volume":"45","author":"M Abe","year":"2022","unstructured":"Abe M, Arima H, Yoshida Y, Fukami A, Sakima A, Metoki H, et al. Optimal blood pressure target to prevent severe hypertension in pregnancy: a systematic review and meta-analysis. Hypertens Res. 2022;45:887\u201399.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01018-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:03:55Z","timestamp":1667779435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01018-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-01018-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"17 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}